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Objectives: To investigate the recollections of parents consenting for their infants to be research subjects
and determine their views about the need for consent.
Subjects: Parents of 154 sick newborn infants enrolled in a randomised trial in the early neonatal period.
All parents had given written consent and received printed information.
Methods: A questionnaire and accompanying letter was sent to the parental home 18 months later. Non-
responders were sent a further questionnaire and letter.
Results: Response rate was 64% (99/154). Some respondents (12%) did not remember being asked to
consent to their baby joining a study, and a further 6% were unsure. Most of the respondents (79%) were
happy, 13% neutral, and 8% unhappy with their decision to give consent. None felt heavy pressure to
agree. Entering the trial caused 24% of respondents to feel more anxious, 56% neutral, and 20% less
anxious about their baby. Most of the respondents (83%) would be unhappy to forgo the consent process
for trials passed by the institutional ethics committee.
Conclusions: A significant proportion of parents who give written consent for a trial in the early neonatal
period do not later remember having done so. Parents who have had experience of neonatal research
would be unhappy for their baby to be enrolled in a study that had ethics committee approval without their
consent being obtained.
W
ritten consent from someone with parental respon-
sibility is generally required before any child is
enrolled in a clinical trial. Although it may safe-
guard the child’s best interests, it is associated with many
difficulties. Concern is expressed about the additional stress
placed on parents.1 The ability of parents to process infor-
mation and make informed decisions under these circum-
stances is questioned.2 Alternatives to the consent process
have been proposed,3 4 but these may be unacceptable to the
parents whose consent would otherwise be sought.5 Serious
concerns about the integrity of the consent process may be
raised later, based on individual recollections.6 7 There are few
data on the experiences of real parents who have been
approached for consent. Snowdon et al8 interviewed the
parents of 21 infants who were enrolled in the ECMO trial.9
They found that some were unsure whether their babies were
in a trial or not. In the Euricon study,10 five of 200 parents
could not remember being asked to give consent for a trial.
We aimed to determine from parents whether they remem-
bered being asked to give consent for a research study and
how they felt the research had affected their experience as
parents of a sick infant.
PATIENTS AND METHODS
The subjects were the parents of 199 infants entered into a
randomised controlled trial of pulmonary function testing
which was conducted in the Simpson Memorial Maternity
Pavilion, Edinburgh between August 1991 and June 1993.11
In all cases the parents were given a printed information
sheet and a detailed verbal description of the trial by a single
individual (BS). Whenever possible, both parents were seen.
Infants were enrolled on the first day that they required
mechanical ventilation, and regular measurements of respira-
tory system compliance were made as long as they remained
ventilated. The intervention group had the test results
supplied to their clinicians with accompanying interpretation
and standardised clinical management advice.
Control infants were managed without the test results or
the advice. Outcome measures included the incidence of
death, chronic lung disease, pneumothorax, and intraven-
tricular haemorrhage. No adverse events were attributed to
the trial.
Several other studies were taking place in the unit at the
time, including randomised trials of alternative surfactant
regimens and a randomised controlled trial of morphine in
ventilated infants. Some infants joined more than one study.
The pulmonary function testing trial was chosen to provide
the cohort for this questionnaire study because it enrolled
more babies than the others.
A short questionnaire was constructed using Likert scales
and closed and open questions. This sought to determine from
the parents (a) whether they remembered signing a consent
form and receiving an information sheet, (b) their perceptions
of the adequacy and accuracy of information given and their
understanding of that information, (c) whether they felt
under pressure to consent and whether they knew that they
could reverse their decision at any time, (d) the effect of the
process on their anxiety levels, and (e) their overall satisfac-
tion looking back on the episode. The questionnaire also
assessed sociodemographic factors. It was piloted on 25
parents recently approached for study consent to check its
face validity and comprehensibility before the final version
was drafted. A copy of the questionnaire can be supplied by
the authors on request. With the assistance of the Stillbirth
and Neonatal Death Society (SANDS), the questionnaire and
accompanying letter were reviewed by bereaved parents, some
of who had participated in neonatal research.
Eighteen months after the trial finished, the questionnaire
and a letter of explanation were sent with a reply paid
envelope to the parents of all infants who were traced.
No indication was given in the letter whether or not the
infant had participated in research, nor were the parents
asked to respond in relation to any specific study. Parents of
twins and triplets were sent a single questionnaire. If no reply
was received, a second copy of the questionnaire and letter
were sent but no further effort was made to contact the
parents. Consent to the questionnaire study was not obtained
as the parents could choose whether or not to complete it.
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Both the original trial and the questionnaire study were
approved by the institutional ethics committee.
The results are presented as the percentage of respondents
who gave a particular answer, with a sensitivity analysis in
parentheses that gives the range of responses if it is assumed
that all non-responders agreed strongly or disagreed strongly
with each question.
RESULTS
The pulmonary function testing trial enrolled 199 infants.
This included 11 twin pairs and two sets of triplets. Of the
184 families, 30 had no traceable forwarding address.
Questionnaires were sent to the remaining 154 families,
and 99 replies (64%) were received. The infants of responding
and non-responding parents were similar in study group
assignment in the original trial. Consent for the original trial
was refused on two occasions. The identity of these parents
was not recorded. Twelve replies came from single mothers,
12 from unmarried couples, and 75 from married couples.
Mothers alone completed 57 questionnaires, fathers alone
four, and both parents together 38.
Of the 99 respondents, 12% (8–44%) could not remember
being approached for consent and did not think that their
infant had participated in a study.
These 12 respondents were evenly distributed across the
original trial with no bias attributable to the length of time
between original recruitment and receipt of the question-
naire. A further 6% (4–40%) remembered being approached
for consent but were unsure whether their infant participated
in a study. Overall, 62% (34–79%) felt completely happy,
17% reasonably happy, 13% neutral, 5% slightly unhappy,
and 3% (2–46%) very unhappy with their decision. The 3%
that were very unhappy did not give the reasons. Most (91%
(50–94%)) remembered that they were free to change their
minds at any time. The information sheet on the original
study was remembered by 70% (40–83%) and was kept by
21% (12–55%).
None of the respondents felt that they were placed under
a lot of pressure to consent, 26% (14–58%) felt a little pres-
sure, and 74% (42–86%) felt no pressure. A quarter (24%
(13–58%)) felt that the study increased their anxiety, 20%
(11–56%) felt less anxious, and 56% (31–76%) felt that it
made no difference. Of those that remembered being
approached, 89% (50–95%) felt that a full explanation of
the studies was given. The explanation was felt to have been
understood completely by 27% (15–60%), reasonably well by
42% (23–68%), a little by 27% (15–60%), and not at all by 4%
(2–47%) of respondents. It was felt by 87% (49–94%) that
being in a study would not affect the general level of care
given to their baby, and 12% (6–51%) even thought that their
baby may get better care. A question asking the parents to
describe what the research study was about was answered by
59 respondents. Answers were too brief to measure the level
of understanding that the parents had, and a number of
different studies were described.
The last question was: ‘‘Before we start any research study
an independent committee made up of doctors and the
general public (the ethics committee) has to agree that it is
safe and worthwhile. Now that you know that, how would
you feel about us being allowed to include your baby in a
study without having to ask your permission as long as
the ethics committee had passed it as safe?’’. The response
was that 60% (38–75%) would be very unhappy and 23%
(15–51%) a little unhappy.
Of the 99 respondents, 39% were college educated and
they were significantly more likely to have felt a little pres-
sure to agree to enter the study than non-college educated
respondents (33% v 19%; x2 test, p,0.05). Otherwise the
responses of these two subgroups were similar.
Of the 154 families who were traced, 20 infants had died in
hospital. Questionnaires were returned by 10 of these
families. Of the eight respondents that remembered giving
their consent, none were unhappy about their decision and
none felt that their baby being in a study increased their
burden of anxiety. Eight of the 10 would be unhappy if
doctors were not required to seek permission to include their
infant in a study.
DISCUSSION
Obtaining consent for research in children presents many
challenges.1 2 12 Data describing the way that real parents
experience the process are few. The infants in our trial were
randomised to different clinical management plans when
critically ill. Eighteen months later, 12% of parents could not
remember giving consent and a further 6% were unsure. Even
when all non-responders are included, at least 8% of parents
could not remember. Our study was performed before the
Griffiths report7 was published.
Snowdon et al8 interviewed the parents of 21 infants who
were enrolled in the UK ECMO trial. All 21 infants had
survived. Some parents were not aware that their baby was in
a trial, and only 12/21 were aware of the random nature of
the treatment allocation. In the Euricon study,10 five of 200
parents could not remember giving consent. In the immedi-
ate period after their infant’s admission to a neonatal unit,
parents remember little of what is said to them by medical
and nursing staff.13 14 It is clear that even when written
consent is obtained and the process is supported by printed
information, an appreciable number of parents will not
remember this later and this could lead to considerable
distress or mistrust. This problem should be addressed
proactively by researchers. Consent is a process that must
be maintained over time.12 This may be facilitated by pro-
viding continuing contact and support, encouraging further
questions, providing parental newsletters, and planning for
sufficient research funding to support such initiatives.
Indeed, in future research into parental views on consent,
these activities may themselves improve the response rate.
Only two parents refused consent for the trial. High consent
rates are obtained for trials in many neonatal units.15 How-
ever, the requirement for written consent is seen by some as a
reason for poor recruitment,16 and alternatives, such as enrol-
ment without consent4 and obtaining consent after randomi-
sation only from those allocated to experimental treatment,
have been suggested.3 Snowdon et al5 interviewed the parents
of surviving infants enrolled into the ECMO trial, and about
half found the concept of Zelen randomisation unacceptable.
More parents of infants not randomised to ECMO found the
concept unacceptable than did parents of infants randomised
to ECMO, indicating that the Zelen approach was rejected by
those who it is aimed to protect. Harth and Thong17 found that
14.5% of parents felt that obtaining consent was unnecessary
as they would do what the doctors said anyway. Zupancic
et al18 found that 32% of parents would prefer their doctor to
decide for them.
We found that, despite having expressed a high degree of
satisfaction with their experience of neonatal research, 83%
of parents would be unhappy for us to be allowed to include
their baby in a study that had ethics committee approval
without having to ask their permission. If all the non-
responders were included, at least 53% of parents would be
unhappy about this. Burgess et al found that 93% of parents
were against the option of letting the doctor decide.19
We sent the questionnaires 18 months after the study
finished to reduce bias from loyalty. We could not use a third
party because the Trust stipulated that the parents be
approached by a doctor from the unit. The institutional
ethics committee initially denied us permission to approach
F322 Stenson, Becher, McIntosh
www.archdischild.com
bereaved parents. Most studies have excluded bereaved
parents. We wrote to a representative of SANDS, who
discussed the study with a group of bereaved parents. They
felt that bereaved parents may gain considerable comfort from
knowing that their baby contributed to research that may
benefit future babies and that they should not be excluded.
On receipt of the responses from SANDS, the ethics committee
gave us permission to approach bereaved parents. Of the 20
bereaved parents, the 10 who responded indicated a high
degree of satisfaction with their children’s involvement in
research and no increased burden of distress. The initial well
intentioned paternalism on the part of the ethics committee
might have denied these parents a voice.
Most parents who responded were happy to have enrolled
their infant in a study. They felt that they were given a full
explanation and knew they were free to change their mind at
any time. They tended not to have felt an increased burden
of anxiety. The response rate of 64% means that the find-
ings should not be overinterpreted. These experiences relate
largely to a single trial in one neonatal unit. It cannot be
assumed that they will apply to other studies or other units.
Some of the infants took part in several studies. This could
have sensitised the parents to trials, making them more likely
to remember, or inoculated them to trials, making them less
stressful. More detailed information may have been obtained
using a more qualitative approach if resources had been
available.
By enrolling their infant in the study, 12% of our
respondents thought that they may get better care. An
inclusion benefit in trials is well recognised.20 Zupancic et al18
found that risk-benefit assessments, attitudes towards
research, and the integrity of the consent process influence
parents consenting for their newborn infants to be research
subjects. Gallo et al21 found that people placed in a
hypothetical situation became more likely to consent for a
trial the worse their outlook. Levene et al22 found that parents
were more likely to consent to a trial when their infant was
critically ill soon after birth than they were a week later. It
may be that our parents were anxious enough about their
infants to consent to almost anything.
The trial required randomisation soon after admission
which limited the time available to parents for consideration.
This is common in neonatal trials. Parents who felt
pressurised were significantly more likely to have been
college educated. Harth and Thong23 found that tertiary
education increased the likelihood of parents refusing
consent. Most patients have not thought about research
before their admission to hospital.24 The sense of pressure
may have reflected a feeling that there was inadequate time
for all of the issues to be fully addressed.
The trial made 24% of parents more anxious. Explaining
the trial necessitated a detailed description of the baby’s
condition and introduced medical uncertainty about the
optimal treatment. Concern about increasing patients’
burden of anxiety can motivate clinicians to give incomplete
information to patients about trials or to avoid enrolling
them.25 Clinicians also acknowledge that obtaining fully
informed consent places an extra emotional burden on them
too.26 A noble intention to protect patients may be partly
motivated by self protection.
It is debatable whether informed consent is ever obtained
in its fullest sense,27 but most of our parents felt satisfied that
they had been adequately informed.28 We have not measured
the quality of the information they were given but rather
their satisfaction with it and the degree to which they felt
that they understood it. However, the facts that about 12% of
parents did not remember giving consent for their child to
participate in a randomised clinical trial and 31% under-
stood little or none of the information provided are of
major concern to all researchers. There is a clear need for
further work involving patient groups looking at ways in
which the process of participation in clinical trials can be
improved.
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Diffuse pneumocephalus caused by neonatal Enterobacter cloacae meningitis
A
5 day old full term male infant
admitted with a two day history of
fever, irritability, and convulsions was
diagnosed as having Enterobacter cloacae sep-
ticaemia and meningitis. A computed tomo-
graphy (CT) brain scan on admission showed
cerebral oedema and areas of low density
signals near the occipital horns of the lateral
ventricles. A repeat CT scan five days after
admission (fig 1) revealed the presence of
diffuse pneumocephalus. T1 weighted mag-
netic resonance images of the brain three -
days later (fig 2), as well as a CT scan two
weeks after admission, showed a pro-
nounced interval increase in the collection
of intracranial air. The baby died from
multiorgan failure 18 days after admission.
Pneumocephalus, defined as the presence
of air or gas in the cranial cavity, is a known
complication of head trauma, neurosurgical
procedures, and cranial irradiation. It has
been reported associated with meningitis
caused by mixed aerobic-anaerobic infection
as well as Clostridium perfringens, Streptococcus
pneumoniae, and Clostridium septicum, mostly
in adult patients.
To our knowledge, this is the first reported
case of diffuse pneumocephalus associated
with Enterobacter cloacae meningitis in a
neonate. The presence of focal areas of
pneumocephalus in the CT scan on admis-
sion before lumbar puncture and its sub-
sequent interval increase in the following
days exclude other causes of pneumocepha-
lus in our patient.
M R Sedaghatian
P Ramachandran
N Rashid
Mafraq Hospital, PB 2951,
Abu Dhabi, United Arab Emirates;
sreza@emirates.net.ae
Figure 1 Computed tomography scan of the brain of a 10 day old male infant showing diffuse
pneumocephalus.
Figure 2 Magnetic resonance image of the brain three days later showing a pronounced interval
increase in intracranial air.
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